Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002340472 | SCV002635662 | uncertain significance | Cardiovascular phenotype | 2022-09-28 | criteria provided, single submitter | clinical testing | The p.R396H variant (also known as c.1187G>A), located in coding exon 9 of the SOS2 gene, results from a G to A substitution at nucleotide position 1187. The arginine at codon 396 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Clinical Genetics Laboratory, |
RCV004697217 | SCV005196847 | uncertain significance | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005096683 | SCV005825340 | likely benign | Noonan syndrome 9 | 2025-01-12 | criteria provided, single submitter | clinical testing |